Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia

All categories
DBCAT005222Pharmacologic class

Agents that have been assigned indications for the lowering of serum lipid levels that do not belong in the statin (aka. Hydroxymethylglutaryl-CoA Reductase Inhibitors) drug class. A DrugBank category of 16 drugs. 16 of them are approved.

Part of
Hypolipidemic Agents
Drugs

What you can answer from here — as of January 15, 2021

16DrugsEach linked to its full drug card
Listed above
30Drug targetsEvery drug–target pair in the class, with bond type
Sign in
4,172Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
8Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Non-statin Hypolipidemic Agents Indicated for Hyperlipidemia share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In